What are the evaluation steps, surgical procedure, risks, and recovery process for living donor liver donation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Living Liver Donation: A Comprehensive Overview

Living liver donation involves removing a portion of a healthy person's liver (typically the right lobe for adult recipients or left lateral segment for children) through major abdominal surgery, carrying a mortality risk of approximately 0.18% and a complication rate affecting roughly one-third of donors. 1

Donor Evaluation Process

The evaluation follows a rigorous, multi-stage protocol designed to ensure donor safety and graft adequacy:

Initial Screening Phase

  • Relationship verification: Most programs require biological or emotional relationship to recipient 2
  • Age assessment: Typically 18-60 years (note: higher age increases complication risk) 3, 4
  • ABO blood type compatibility
  • Basic medical history and physical examination to exclude significant comorbidities

Advanced Imaging and Anatomical Assessment

Contrast-enhanced CT scan is the critical early step, identifying approximately 64% of unsuitable donors and, when combined with basic testing, excludes 87% of ineligible candidates 4. This imaging evaluates:

  • Liver volume: Donor remnant must be ≥30% of pre-donation volume; graft must be ≥0.8% of recipient body weight 1, 5
  • Vascular anatomy: Hepatic artery, portal vein, and hepatic vein mapping (anatomic variants present in up to 50% of population) 6
  • Biliary anatomy: Bile duct configuration (3-4mm diameter structures require precise mapping) 1
  • Hepatic steatosis: Significant fatty liver is a common exclusion criterion 3, 4

Medical Workup

  • Comprehensive laboratory studies including liver function tests, coagulation profile
  • Screening for infectious diseases (HBV, HCV, HIV, CMV, EBV)
  • Cardiopulmonary assessment
  • Procoagulant condition screening 5
  • Age-appropriate cancer screening

Psychosocial Evaluation

Mandatory assessment to evaluate:

  • Voluntary nature of donation without coercion
  • Understanding of risks and outcomes
  • Psychological readiness
  • Social support systems 7, 2

The Surgical Procedure

For Adult Recipients (Right Lobe Donation)

  • Segments removed: V-VIII (right hepatectomy)
  • Structures isolated: Right hepatic artery, right portal vein, right bile duct, right hepatic vein
  • Operation time: Approximately 6-7 hours 8
  • Blood loss: Average 300ml (range 100-500ml) 8
  • Technical complexity: Meticulous dissection required; some grafts include middle hepatic vein (increases donor risk) 1

For Pediatric Recipients (Left Lateral Segment)

  • Segments removed: II-III
  • Lower complication rates than right lobe donation
  • Faster recovery: More rapid normalization of bilirubin and coagulation parameters 1

Risks and Complications

Mortality Risk

The donor mortality rate is 0.18% according to European registry data, though this figure is considered under-reported 1. The reality that a healthy individual may die from donation has significantly impacted acceptance in Western countries.

Morbidity Rates

  • Overall complication rate: 38% for right lobe donors 1
  • 11-20% complication rate across all donor types 7, 2
  • Right lobe donation carries significantly higher risk than left lobe or left lateral segment donation 1

Specific Complications (by Clavien-Dindo Classification)

Most Common (Type I-II):

  • Biliary fistula/leak: Most frequent complication, usually managed conservatively 1
  • Wound complications
  • Transient liver dysfunction

Moderate (Type IIIa-IIIb):

  • Bile leak requiring intervention (occurred in 1/74 donors in one series) 8
  • Hemorrhage requiring reoperation
  • Need for rehospitalization (affects some donors) 1

Severe (Type IV-V):

  • Liver failure
  • Death (0.18% risk) 1

Laboratory Changes Post-Donation

  • Peak ALT: Average 229.5 U/L, normalizes in ~13 days 8
  • Peak bilirubin: Average 78.7 μmol/L, normalizes in ~9 days 8
  • Right lobe donors show slower normalization than left lobe donors 1

Recovery Process

Hospital Stay

  • Average duration: 14 days (range 7-28 days) 8
  • Shorter for left lateral segment donors

Return to Normal Function

  • Liver regeneration: Begins immediately post-operatively
  • Return to work: Most donors resume normal activities and work within weeks to months 8
  • Long-term outcomes: The vast majority of donors return to completely normal life 7, 2

Follow-up Requirements

  • Close postoperative monitoring for complications
  • Serial laboratory testing to track liver function recovery
  • Long-term surveillance (though protocols vary by center)

Critical Safety Considerations

Key factors that increase donor risk and should prompt careful consideration or exclusion:

  1. Right lobe donation vs. left lobe (higher complication rate: 23.3% vs. 11.5%) 7
  2. Advanced donor age (significant risk factor for complications ≥Grade II) 4
  3. Obesity or hepatic steatosis (common exclusion criteria) 3, 4
  4. Small remnant liver volume (<30% of original) 5
  5. Complex vascular or biliary anatomy 6

Common Pitfalls to Avoid

  • Inadequate volumetric assessment: Errors occur in up to 10% of cases, potentially endangering donor safety 6
  • Insufficient anatomical mapping: Missing vascular or biliary variants (present in 50% of population) can lead to intraoperative complications 6
  • Rushing evaluation: Approximately 43-68% of potential donors are ultimately declined; thorough evaluation prevents unnecessary risk 3, 4
  • Underestimating psychosocial factors: Coercion or inadequate understanding of risks compromises informed consent 7

The decision to proceed with living donation requires balancing the recipient's urgent need against the donor's safety, with donor welfare always taking absolute priority. Programs should concentrate experience in high-volume centers to minimize risks and optimize outcomes for all stakeholders 5.

References

Research

Our Living Donor Protocol for Liver Transplant: A SingleCenter Experience.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2020

Research

Staged preoperative evaluation of potential living donors for liver transplantation.

Translational gastroenterology and hepatology, 2025

Research

Optimization of surgical evaluation algorithms for living donor liver transplantation.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.